University of Pennsylvania, Philadelphia, PA, USA.
Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):109-18. doi: 10.1167/iovs.10-6113.
Iron dysregulation can cause retinal disease, yet retinal iron regulatory mechanisms are incompletely understood. The peptide hormone hepcidin (Hepc) limits iron uptake from the intestine by triggering degradation of the iron transporter ferroportin (Fpn). Given that Hepc is expressed in the retina and Fpn is expressed in cells constituting the blood-retinal barrier, the authors tested whether the retina may produce Hepc to limit retinal iron import.
Retinas of Hepc(-/-) mice were analyzed by histology, autofluorescence spectral analysis, atomic absorption spectrophotometry, Perls' iron stain, and immunofluorescence to assess iron-handling proteins. Retinal Hepc mRNA was evaluated through qPCR after intravitreal iron injection. Mechanisms of retinal Hepc upregulation were tested by Western blot analysis. A retinal capillary endothelial cell culture system was used to assess the effect of exogenous Hepc on Fpn.
Hepc(-/-) mice experienced age-dependent increases in retinal iron followed by retinal degeneration with autofluorescent RPE, photoreceptor death, and subretinal neovascularization. Hepc(-/-) mice had increased Fpn immunoreactivity in vascular endothelial cells. Conversely, in cultured retinal capillary endothelial cells, exogenous Hepc decreased both Fpn levels and iron transport. The retina can sense increased iron levels, upregulating Hepc after phosphorylation of extracellular signal regulated kinases.
These findings indicate that Hepc is essential for retinal iron regulation. In the absence of Hepc, retinal degeneration occurs. Increases in Hepc mRNA levels after intravitreal iron injection combined with Hepc-mediated decreases in iron export from cultured retinal capillary endothelial cells suggest that the retina may use Hepc for its tissue-specific iron regulation.
铁代谢失调可导致视网膜疾病,但视网膜铁调节机制尚不完全清楚。肽类激素铁调素(Hepc)通过触发铁转运蛋白铁蛋白(Fpn)的降解,限制肠道对铁的摄取。鉴于 Hepc 在视网膜中表达,而 Fpn 在构成血视网膜屏障的细胞中表达,作者研究了视网膜是否能产生 Hepc 来限制视网膜铁的摄取。
通过组织学、自发荧光光谱分析、原子吸收分光光度法、Perls 铁染色和免疫荧光检测来评估铁处理蛋白,分析 Hepc(-/-)小鼠的视网膜。通过眼内注射铁后进行 qPCR 评估视网膜 Hepc mRNA。通过 Western blot 分析测试视网膜 Hepc 上调的机制。使用视网膜毛细血管内皮细胞培养系统评估外源性 Hepc 对 Fpn 的影响。
Hepc(-/-)小鼠的视网膜铁水平随年龄增长而增加,随后出现视网膜变性,伴有 RPE 自发荧光、光感受器死亡和脉络膜新生血管。Hepc(-/-)小鼠血管内皮细胞中 Fpn 免疫反应性增加。相反,在培养的视网膜毛细血管内皮细胞中,外源性 Hepc 降低了 Fpn 水平和铁转运。视网膜可以感知铁水平的升高,在细胞外信号调节激酶磷酸化后上调 Hepc。
这些发现表明 Hepc 对视网膜铁调节至关重要。在没有 Hepc 的情况下,视网膜发生变性。眼内注射铁后 Hepc mRNA 水平增加,以及外源性 Hepc 降低培养的视网膜毛细血管内皮细胞中铁的输出,提示视网膜可能使用 Hepc 进行其组织特异性的铁调节。